TickerFacts.

Company research / SNTI

Senti Biosciences Holdings, Inc. (SNTI)

Build a valuation ↗↓ Download CSV

CIK 0001854270 · Nasdaq · Biological Products, (No Diagnostic Substances)

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Senti Biosciences Holdings, Inc. reported revenue of $22.0K.

Key ratios (year ended 2025-12-31)

-312631.8%
Operating margin
-279263.6%
Net margin
-1099.3%
Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 8-K · 2026-09-04

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended2025-12-312024-12-312023-12-312022-12-312022-06-082021-12-312021-02-282020-12-31
Revenue$22.0K$0$1.98M$3.29M—$2.29M——
Operating Income-$68.78M-$61.04M-$92.73M-$62.08M—-$40.45M——
Net Income-$61.44M-$52.79M-$71.06M-$58.21M—-$55.32M——
EPS (Diluted)$-2.73$-12.03$-16.01$-2.23—$-19.00——
Total Assets$51.22M$97.84M$119.48M$180.79M—$96.70M——
Total Liabilities$45.63M$47.09M$52.57M$53.53M—$36.33M——
Shareholders' Equity$5.59M$25.65M$66.91M$127.26M—-$111.46M$0-$58.71M
Cash & Equivalents$16.42M$48.28M$35.93M$57.62M—$56.03M$0—
Operating Cash Flow-$43.44M-$41.40M-$52.40M-$34.90M—-$34.63M——
Capital Expenditures$196.0K$26.0K$12.04M$41.37M—$5.54M——
Shares Outstanding30.88M4.83M4.57M44.06M43.37M2.97M——
Weighted Average Diluted Shares22.48M4.60M4.44M26.11M—2.91M——
EPS (Basic)$-2.73$-12.03$-16.01$-2.23—$-19.00——